<?xml version="1.0"?>
<Articles JournalTitle="Current Journal of Neurology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Optic coherence tomography findings in relapsing-remitting multiple sclerosis patients of the northwest of Iran.</title>
    <FirstPage>81</FirstPage>
    <LastPage>86</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mahnaz</FirstName>
        <LastName>Talebi</LastName>
        <affiliation locale="en_US">Associate Professor, Department of Neurology AND Neurosciences Research Center (NSRC), Tabriz University of Medical Sciences, Tabriz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Nikanfar</LastName>
        <affiliation locale="en_US">Associate Professor, Department of Neurology AND Neurosciences Research Center (NSRC), Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Rana</FirstName>
        <LastName>Sorkhabi</LastName>
        <affiliation locale="en_US">Associate Professor, Department of Ophthalmology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ehsan</FirstName>
        <LastName>Sharifipour</LastName>
        <affiliation locale="en_US">Resident, Department of Neurology AND Neurosciences Research Center (NSRC), Student Research Committee, Tabriz University of Medical Sciences, Imam Reza Hospital, Tabriz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mansour</FirstName>
        <LastName>Bahrebar</LastName>
        <affiliation locale="en_US">Resident, Department of Neurology AND Neurosciences Research Center (NSRC), Student Research Committee, Tabriz University of Medical Sciences, Imam Reza Hospital, Tabriz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Kiavar</LastName>
        <affiliation locale="en_US">Resident, Department of Ophthalmology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sasan</FirstName>
        <LastName>Andalib</LastName>
        <affiliation locale="en_US">PhD Student, Neurosciences Research Center (NSRC), Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hadi Mohammad</FirstName>
        <LastName>Khanli</LastName>
        <affiliation locale="en_US">Neurologist, Neurosciences Research Center (NSRC), Tabriz, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Optical coherence tomography (OCT) is a simple, high-resolution technique to quantify the thickness of retinal nerve fiber layer (RNFL) and macula volume, which provide an indirect measurement of axonal damage in multiple sclerosis (MS). This study aimed to evaluate OCT finding in relapsing-remitting MS patients of the northwest of Iran and compare them with a normal control group.
Methods:In a cross-sectional, descriptive, analytic study, 60 patients with MS as case group and 60 patients as controls were studied. Total macular volume (TMV) and retinal nerve fiber layer (RNFL) in perioptic disk area (3.4 millimeter around the disk) and macula was measured using Stratus 3000 in circular form. These findings were compared between the two groups and their relationship with the duration and severity of MS [based on Expanded Disability Status Scale (EDSS)] and history of optic neuritis were evaluated.
Results:In total, 35 men and 85 women with a mean age of 34.8 years were evaluated.The mean RNFL in MS patients were 231.9 and 233.1 micrometers in right and left eyes; while they were 246.7 and 250.4 micrometers in right and left eyes of healthy subjects, respectively. This difference in thickness of RNFL in total measure and all quadrants around the optic disk and TMV between case and control groups was analytically meaningful (P = 0.001 and P = 0.001 for right and left eyes, respectively). The mean thickness of RNFL in patients with optic neuritis was significantly lower than other patients in right and left eyes (P = 0.042 and P = 0.005). There was a significant correlation between most of OCT findings and the MS disease duration and EDSS.
Conclusion:Findings of the present study in the northwest of Iran buttress the idea that RNFL thickness can be greatly affected by MS. Our results also indicate that this effect is associated with ON and MS duration and severity.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/654</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/654/148</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Safety assessment of anticoagulation therapy in patients with hemorrhagic cerebral venous thrombosis.</title>
    <FirstPage>87</FirstPage>
    <LastPage>91</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Kavian</FirstName>
        <LastName>Ghandehari</LastName>
        <affiliation locale="en_US">Professor, Department of Cerebrovascular Disease AND Neurocognitive Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hamid Reza</FirstName>
        <LastName>Riasi</LastName>
        <affiliation locale="en_US">Assistant Professor, Department of Neurology, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Noureddine</LastName>
        <affiliation locale="en_US">Resident, Department of Neurology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Shahram</FirstName>
        <LastName>Masoudinezhad</LastName>
        <affiliation locale="en_US">Resident, Department of Neurology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Siamak</FirstName>
        <LastName>Yazdani</LastName>
        <affiliation locale="en_US">Resident, Department of Neurology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Mousavi</FirstName>
        <LastName>Mirzae</LastName>
        <affiliation locale="en_US">Resident, Department of Neurology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Atena Sharifi</FirstName>
        <LastName>Razavi</LastName>
        <affiliation locale="en_US">Resident, Department of Neurology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Kosar</FirstName>
        <LastName>Ghandehari</LastName>
        <affiliation locale="en_US">Researcher, Neurocognitive Research Center, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Anticoagulation therapy is a routine treatment in patients with hemorrhagic cerebral venous thrombosis (CVT). However, fear of hemorrhagic complications and deterioration course following anticoagulation often disturbs the responsible physician.
Methods:This was a Prospective observational study on consecutive CVT patients with hemorrhagic venous infarction or subarachnoid hemorrhage (SAH) admitted in Ghaem Hospital, Mashhad, Iran, during 2006-2012. The diagnosis of CVT in suspected cases was confirmed by magnetic resonance imaging/magnetic resonance venography (MRI/MRV), and computerized tomography (CT) angiography following established diagnostic criteria. Demographic data, clinical manifestations from onset to end of the observation period, location of thrombus, location and size of infarction and hemorrhage, and clinical course during treatment were recorded. Choice of the treatment was left to the opinion of the treating physician. Clinical course during 1 week of treatment was assessed based on the baseline modified National Institute of Health Stroke Scale (NIHSS) score. Three or more points decrease or increase of modified NIHSS after 1 week of treatment was considered as improvement or deterioration courses, respectively. Other clinical courses were categorized as stabilization course.
Results:102 hemorrhagic CVT patients (80 females, 22 males) with mean age of 38.6 &#xB1; 8 years were prospectively investigated. Of the 102 hemorrhagic CVT patients in the acute phase, 52 patients (50.9%) were anticoagulated with adjusted dose intravenous heparin infusion and 50 cases (49.1%) received subcutaneous enoxaparin 1mg/Kg twice daily. Decreased consciousness had a significant effect on the clinical course of the patients (X(2) = 9.493, df = 2, P = 0.009). Presence of SAH had no significant effect on the clinical course of our anticoagulated hemorrhagic CVT cases (X(2) = 0.304, df = 2, P = 0.914). Extension of Infarction in more than two thirds of a hemisphere had a significant influence on the distribution of clinical courses (X(2) = 5.867, df = 2, P = 0.044). Difference in distribution of clinical course among the two groups of our hemorrhagic CVT patients was not significant (X(2) = 8.14, df = 1, P = 0.87).
Conclusion:Patients with hemorrhagic CVT without other contraindication for anticoagulation should be treated either with dose-adjusted intravenous heparin or body-weight-adjusted subcutaneous low molecular-weight heparin.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/653</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/653/149</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">High sensitivity C-reactive protein levels in Acute Ischemic Stroke and subtypes: A study from a tertiary care center.</title>
    <FirstPage>92</FirstPage>
    <LastPage>97</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Jaydip Ray</FirstName>
        <LastName>Chaudhuri</LastName>
        <affiliation locale="en_US">Department of Neurology,Yashoda Hospital, Hyderabad, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Kandadai Rukmini</FirstName>
        <LastName>Mridula</LastName>
        <affiliation locale="en_US">Assistant Professor, Department of Neurology, Nizams&#x2019;s Institute of Medical Sciences, Hyderabad, India</affiliation>
      </Author>
      <Author>
        <FirstName>Matapathi</FirstName>
        <LastName>Umamahesh</LastName>
        <affiliation locale="en_US">Department of Radiology, Yashoda Hospital, Hyderabad, India</affiliation>
      </Author>
      <Author>
        <FirstName>Alluri</FirstName>
        <LastName>Swathi</LastName>
        <affiliation locale="en_US">Clinical Register, Department of Neurology, Yashoda Hospital, Hyderabad, India</affiliation>
      </Author>
      <Author>
        <FirstName>Banda</FirstName>
        <LastName>Balaraju</LastName>
        <affiliation locale="en_US">Department of Medicine, Yashoda Hospital, Hyderabad, India</affiliation>
      </Author>
      <Author>
        <FirstName>Venkata Chandrasekher Srinivasarao</FirstName>
        <LastName>Bandaru</LastName>
        <affiliation locale="en_US">Research Coordinator, Department of Neurology and Clinical Research, Yashoda Hospital, Hyderabad, India</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Stroke is a heterogeneous disease with several risk factors. High sensitivity C-reactive protein (hsCRP) is a marker for cardiovascular and cerebrovascular diseases. Recent studies have shown that high hsCRP level is a risk factor for ischemic stroke. The objective of our study was to investigate the association of high hsCRP (&gt; 3 mg/L) levels with ischemic stroke and its subtypes in Indian patients.
Methods: We recruited 210 consecutive acute stroke patients and 150 age and sex matched controls. Stroke patients were admitted within 72 hours of onset, at Yashoda Hospital, Hyderabad, India. The study period was from January 2011 to December 2012. All patients underwent tests as per standard protocol for stroke workup. Serum hsCRP level was assessed in all stroke patients and controls on the day of admission.
Results:The mean hsCRP was significantly higher in stroke patients (3.8 &#xB1; 2.5) than controls (1.8 &#xB1; 1.5) (P &lt; 0.001). High hsCRP had higher frequency in stroke patients 130 (61.9%) compared to controls 10 (6.6%), P &lt; 0.001. High hsCRP level was more prevalent in the stroke subtypes of cardioembolic stroke (83.3%) and large artery atherosclerosis (72%). High hsCRP level was significantly associated with hypercholesterolemia (P = 0.001), age (P = 0.01), and mortality (0.04). After adjustment of regression analysis it was observed that high level hsCRP is independently associated with acute ischemic stroke (Odds 4.5; 95% CI: 2.5-12.2); especially the stroke subtypes of cardioembolic stroke, (odds ratio 3.4, 95% CI: 1.9-10.5) and large artery atherosclerosis (odds ratio 2.1, 95% CI: 1.5-3.8).
Conclusion:High hsCRP level is strongly associated with and an independent predictor of acute ischemic stroke. The association was found in all ischemic stroke subtypes.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/652</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/652/150</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Cardiovascular risk factors and migraine without aura: A case-control study.</title>
    <FirstPage>98</FirstPage>
    <LastPage>101</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Samaneh Aalami</FirstName>
        <LastName>Harandi</LastName>
        <affiliation locale="en_US">Cardiology Resident, Department of Cardiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mansoureh</FirstName>
        <LastName>Togha</LastName>
        <affiliation locale="en_US">Professor, Department of Neurology AND Iranian Neurological Research Center, Sina Hospital, Tehran University of Medical&#xD;
Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Azadeh</FirstName>
        <LastName>Sadatnaseri</LastName>
        <affiliation locale="en_US">Department of Cardiology AND Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>S Hamed</FirstName>
        <LastName>Hosseini</LastName>
        <affiliation locale="en_US">Department of Epidemiology and Biostatistics, School of Public Health AND Knowledge Utilization Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Soodeh Razeghi</FirstName>
        <LastName>Jahromi</LastName>
        <affiliation locale="en_US">Endocrine and Metabolic Research Center, Obesity group, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Migraine with aura (MA) has been identified as a risk factor for cardiovascular disease. Previous observation has also found higher prevalence of cardiovascular risk factors in migraineurs without aura (MO), but the results have been conflicting. The present study was conducted to assess the association between cardiovascular risk factors and migraine without aura among Iranians.
Methods: In our study the prevalence of cardiovascular risk factors, including hypertension, hyperglycemia, dyslipidemia, obesity, cigarette smoking, and family history of early coronary artery disease, were studied in 347 migraineurs without aura and 267 non-migraineurs. The odds ratio (ORs) with 95% confidence interval (95% CI) was used to assess the strength of the association.
Results:Patients with migraine without aura were at an increased risk of developing hypertension (ORadj = 1.9; P = 0.029), but there was no difference in other cardiovascular risk profiles, including hyperglycemia, dyslipidemia, obesity, cigarette smoking, and family history of early coronary artery disease.
Conclusion: Our study revealed that the prevalence of hypertension was higher in migraineurs without aura in comparison with non-migraineurs. Therefore, physicians are supposed to be more vigilant in examining these patients and take care not to prescribe medications that may provoke hypertension.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/651</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/651/151</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Validation of the Persian version of the 40-item amyotrophic lateral sclerosis assessment questionnaire.</title>
    <FirstPage>102</FirstPage>
    <LastPage>105</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Hosein</FirstName>
        <LastName>Shamshiri</LastName>
        <affiliation locale="en_US">Resident, Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Eshraghian</LastName>
        <affiliation locale="en_US">Professor, Department of Statistics and Epidemiology, School of Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nastaran</FirstName>
        <LastName>Ameli</LastName>
        <affiliation locale="en_US">Department of Biostatistics and Epidemiology, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Shahriar</FirstName>
        <LastName>Nafissi</LastName>
        <affiliation locale="en_US">Associate professor, Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: As a disease of motor nervous system (motor neuron&#xA0; disease), amyotrophic&#xA0; lateral&#xA0; sclerosis (ALS)&#xA0; has&#xA0; a great&#xA0; impact&#xA0; on&#xA0; several&#xA0; aspects&#xA0; of&#xA0; quality&#xA0; of&#xA0; life (QoL). Generic questionnaires of QoL do not address all the especial features&#xA0; of ALS and&#xA0; therefore&#xA0; translation&#xA0; and&#xA0; validation of disease specific questionnaires such as Amyotrophic Lateral Sclerosis Assessment&#xA0; Questionnaire&#xA0; 40-item&#xA0; (ALSAQ-40)&#xA0; is necessary for assessment of patients with different languages. The aim of this study was to review the validation of the Persian version of the ALSAQ-40.
Methods:&#xA0; Meticulously&#xA0; translated ALSAQ-40&#xA0;&#xA0; was completed by 21 ALS patients. Internal reliability was evaluated&#xA0;&#xA0; using&#xA0; Cronbach&#x2019;s&#xA0; alpha&#xA0; coefficient&#xA0; and item- total correlation&#xA0; was also used&#xA0; to evaluate&#xA0; the correlation of each&#xA0; question&#xA0; with total&#xA0; score.Validity was evaluated through&#xA0; comparison with Amyotrophic Lateral Sclerosis Functional Rating Scale-revised (ALSFRS-r)and the 36-Itemhort Form Health Survey (SF-36). 
Results: Cronbach&#x2019;s alpha coe&lt;cient was 0.91-0.96 for different scales of the ALSAQ-40. All the 40 questions of the questionnaire had correlation greater&#xA0; than 0.5. Correlation coefficient of all the related scales of the Persian version of ALSAQ-40, SF-36 and ALSFRS-r was greater&#xA0; than&#xA0; 0.59 with P value &lt; 0.001.
Conclusion: Measures of the Cronbach&#x2019;s alpha coefficient and item-total correlation demonstrated reliability and consistency of the questionnaire, and correlation coefficients confirmed the validity of different items in the questionnaire. This study showed that the Persian version of the ALSAQ-40 is a reliable and valid questionnaire for the evaluation of QoL in ALS patients with Persian language.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/650</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/650/152</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Secondary headaches attributed to arterial hypertension.</title>
    <FirstPage>106</FirstPage>
    <LastPage>110</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Farhad</FirstName>
        <LastName>Assarzadegan</LastName>
        <affiliation locale="en_US">Assistant Professor, Department of Neurology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mostafa</FirstName>
        <LastName>Asadollahi</LastName>
        <affiliation locale="en_US">Assistant Professor, Department of Neurology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Omid</FirstName>
        <LastName>Hesami</LastName>
        <affiliation locale="en_US">Assistant Professor, Department of Neurology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Omid</FirstName>
      effects of&#xA0; one-shot low-dosage intratympanic&#xA0;&#xA0; gentamicin&#xA0;&#xA0; on&#xA0; vertigo control, auditory outcomes&#xA0; and&#xA0; findings of computerized&#xA0; dynamic posturography&#xA0; and&#xA0;&#xA0; vestibular&#xA0; evoked&#xA0; myogenic potentials in patients with unilateral M&#xE9;ni&#xE8;re&#x2019;s disease.
Methods: In a prospective&#xA0; clinical study, 30 patients&#xA0; with unilateral&#xA0; M&#xE9;ni&#xE8;re&#x2019;s&#xA0; disease&#xA0; were&#xA0; treated&#xA0; with one-shot intratympanic injection of 20 milligrams gentamicin. Main outcome&#xA0;&#xA0;&#xA0;&#xA0; measures&#xA0; included clinical,&#xA0; audiometric, postural&#xA0;&#xA0; and&#xA0; vestibular&#xA0; outcomes evaluated 1 and&#xA0; 9 months after the treatment.
Results:&#xA0; Mean&#xA0; vertigo&#xA0; attacks&#xA0; frequency,&#xA0; pure&#xA0;&#xA0; tone average&#xA0; threshold&#xA0; and functional level scale significantly decreased after the treatment (P &lt; 0.05). Effective vertigo control (class A and B) obtained in 95.8% of the patients. In total, 75% of patients&#xA0; reported decrease&#xA0; in both&#xA0; aural fullness and&#xA0; tinnitus.&#xA0;&#xA0;&#xA0; Vestibular&#xA0; evoked myogenic potentials&#xA0; became&#xA0; absent&#xA0; in all the&#xA0; patients&#xA0; but&#xA0; four of them. Posturographic scores were improved after the treatment.
Conclusion: One-shot&#xA0; low-dosage&#xA0; gentamicin&#xA0; was effective&#xA0;&#xA0; in&#xA0;&#xA0; controlling vertigo attacks&#xA0; in M&#xE9;ni&#xE8;re&#x2019;s disease&#xA0; and&#xA0; has&#xA0; useful&#xA0; effects on&#xA0; aural&#xA0; fullness and tinnitus&#xA0; of patients&#xA0; as well. Postural and&#xA0; vestibular tests only have adjunctive role for monitoring&#xA0; therapeutic responses in intratympanic gentamicin-therapy.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/627</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/627/175</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Thymic pathological examination of non-thymomatous myasthenia gravis patients: A pilot study for prediction of outcome.</title>
    <FirstPage>40</FirstPage>
    <LastPage>44</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Zeinab</FirstName>
        <LastName>Peimani</LastName>
        <affiliation locale="en_US">Student Research Comittee, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Amin</FirstName>
        <LastName>Banihashemi</LastName>
        <affiliation locale="en_US">Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Niloofar</FirstName>
        <LastName>Namazi</LastName>
        <affiliation locale="en_US">Student Research Comittee, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Anahid</FirstName>
        <LastName>Safari</LastName>
        <affiliation locale="en_US">Department of Pharmacology, School of Medicine, Islamic Azad University, Kazeroon Branch, Kazeroon, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ahmad</FirstName>
        <LastName>Monabati</LastName>
        <affiliation locale="en_US">Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mehra</FirstName>
        <LastName>Mojallal</LastName>
        <affiliation locale="en_US">Department of Pathology, Dena Hospital, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Afshin</FirstName>
        <LastName>Borhani-Haghighi</LastName>
        <affiliation locale="en_US">Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran ; Department of Neurology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background:&#xA0; Myasthenia&#xA0; gravis (MG) is an&#xA0; autoimmune disorder&#xA0;&#xA0; characterized&#xA0;&#xA0; by&#xA0; weakness&#xA0;&#xA0; and&#xA0;&#xA0; fatigability&#xA0; of skeletal muscles. The aim of this study was to determine if pathological characteristics in non-thymomatous patients of MG would correlate with prognosis in a three year follow up.
Methods:&#xA0; Patients&#xA0; who&#xA0; had&#xA0; had&#xA0; their&#xA0; thymectomy&#xA0;&#xA0; at least&#xA0; three&#xA0; years prior to&#xA0; the&#xA0; study&#xA0; were&#xA0; selected&#xA0; from three&#xA0; hospitals&#xA0; and were followed for 3 years. Prognosis was assessed&#xA0; via a devised&#xA0; prognostic&#xA0; scoring system. A pathological&#xA0; exam of the specimen&#xA0; from the thymus was done&#xA0; using the following immunohistochemical markers: Bcl2, CD 3, CD 4, CD 5, CD 7, CD 10, CD 20cy, CD 23, CD 43, and Ki67.
Results: Fifteen patients&#xA0; fulfilled the inclusion criteria and had a complete&#xA0; follow-up. This included&#xA0; 3 males and 12 females with a mean age of 36.6 years at the start of the&#xA0; study. The dominant&#xA0; cell population was T lymphocytes. All T cells expressed&#xA0; CD 3, CD 43, CD 5, and&#xA0; Bcl-2. In&#xA0; 2 patient , CD 10 marker was positive in T cells. B cells were negative for activation marker CD 23, except for germinal center&#xA0;&#xA0; dendritic&#xA0;&#xA0; cells.&#xA0; Due&#xA0; to&#xA0; the&#xA0; limited&#xA0; number&#xA0;&#xA0; of patients&#xA0; in the study, the power of the study would not allow for an analysis to assess correlation between histopathological data and prognosis.
Conclusion: This pilot study was an attempt to discover any prognostic indices from the histopathological examination&#xA0; of the resected&#xA0; thymic tissue in the patients with myasthenia gravis.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/626</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/626/176</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Increased carotid intima-media thickness in scuba divers.</title>
    <FirstPage>45</FirstPage>
    <LastPage>47</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Mehrpour</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Iran University of Medical Sciences AND Iranian Center of Neurological Research (ICNR), Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Saeed</FirstName>
        <LastName>Rezaali</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Islamic Azad University, Tehran Medical Branch, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Narges Sadat</FirstName>
        <LastName>Shams-Hosseini</LastName>
        <affiliation locale="en_US">Department of Occupational and Environmental Medicine AND Center for Research on Occupational Diseases, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Scuba divers work in high pressure conditions which may cause some changes in physiological status to adapt to this situation. In this study, the carotid intima-media thickness (CIMT) was assessed in divers as a risk factor of cerebrovascular and cardiovascular disorders.
Methods: This historical cohort study was performed on 16 male professional scuba divers as case group and 30 healthy people as controls with age range of 26-66 years. CIMT of both carotids of supine participants was measured by a 10 MHz linear ultrasonic probe quantitatively. Relationship between experience of diving and carotid IMT was evaluated.
Results: All the participants were males (mean age 42.9 &#xB1; 10.58. and for the control group was (47.05 &#xB1; 12.31 years). The mean right CIMT in divers and control group was 524.31 &#xB1; 149.40 and 443.66 &#xB1; 59.62 micrometer, respectively. Furthermore, the mean left CIMT in divers and control group was 624.57 &#xB1; 116.15 and 458.44 &#xB1; 49.56 micrometer, respectively. Conclusion: The findings demonstrated that long-term occupational diving leads to increased intima-media thickness in scuba divers.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/625</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/625/177</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Amyloid-based therapies did fail again! It is the right time to change our vision on building block of Alzheimer's disease.</title>
    <FirstPage>48</FirstPage>
    <LastPage>49</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Morteza</FirstName>
        <LastName>Mahmoudi</LastName>
        <affiliation locale="en_US">Department of Nanotechnology AND Nanotechnology Research Center, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">#No Abstract#</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/624</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/624/178</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Prevalence of Lhermitte's sign in multiple sclerosis versus neuromyelitis optica.</title>
    <FirstPage>50</FirstPage>
    <LastPage>51</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Etemadifar</LastName>
        <affiliation locale="en_US">Department of Neurology, Isfahan Neurosciences Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Noushin</FirstName>
        <LastName>Mehrbod</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Leila</FirstName>
        <LastName>Dehghani</LastName>
        <affiliation locale="en_US">Department of Medical Sciences, School of Medicine, Islamic Azad University, Najafabad Branch, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Aryan</FirstName>
        <LastName>Golabbakhsh</LastName>
        <affiliation locale="en_US">Medical Students' Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <Fir